Dexamethasone palmitate is a feasible option for the treatment of chronic graft-vs-host disease, particularly with macrophage hyperactivation.
Yoshinaga KurosawaDaisuke MoritaTakumi ShibazakiKazutoshi KomoriMitsuo MotobayashiTomonari ShigemuraMiyuki TanakaYozo NakazawaPublished in: Pediatric transplantation (2019)
Keyphrases